CKAP2L and central nervous system cancer: After transfection of siCKAP2L or siRNA (scramble siRNA) into U87MG and U118MG glioma cells, the expression of CKAP2L was substantially reduced at both 25 nM and 37.5 nM siRNA supplementation (Figure 5A,B).